1. Home >
  2. Investors >
  3. Growth Capital Firm >
  4. United States >
  5. Signet Healthcare Partners

Signet Healthcare Partners Mergers and Acquisitions Summary

Growth Capital Firm Profile

In the last 3 years, Signet Healthcare Partners has invested in 5 companies.

Signet Healthcare Partners’ most common sectors for investment arelife science (82%) and medical products (19%) . The Firm’s most common investment types include growth capital (69%) and venture (25%). In total, Signet Healthcare Partners has invested in 6 US states and 8 different countries.

In the last 3 years, Signet Healthcare Partners has exited 2 companies. The Firm’s most common exit type is trade sale (100%).

Subscribe to Mergr to view Signet Healthcare Partners’ full profile and discover more middle-market growth capital firm investors just like it.

M&A Summary

  • M&A Total Activity18
    • M&A Buy Activity16
    • M&A Sell Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 8
  • M&A Buy/Sell Connections 5
  • M&A Advisors 4

Signet Healthcare Partners

Signet Healthcare Partners

Carnegie Hall Tower 152 West 57th Street, 59th Fl,
New York, 10019
United States
(646) 840-4990
www.signethealthcarepartners.com

Signet Healthcare Partners is a growth capital firm focused on the healthcare sector. Specific areas of interest include specialty pharmaceuticals, pharmaceutical services, medical devices, and diagnostics. Signet will consider opportunities throughout North America and Europe and looks to commit $10 to $50 million per transaction. Signet Healthcare Partners was established in 1998 and is headquartered in New York, New York.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Growth Capital, Venture

Geographic Preferences: East US, Midwest US, South US, West US, Canada, United Kingdom, Western Europe, Nordic, Central Asia/India

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size 10 50
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (1.4/yr) # 9 2 2 1 1 1 16
Sell (0.4/yr) # - - - - 1 1 2
  18

Most Recent M&A

Company Date Value Type
NorthX Biologics Matfors AB 2025-05-14 - Growth Capital
Matfors, Sweden · www.nxbio.com
Pharmaceutics International, Inc. 2025-02-04 - Trade Sale
Hunt Valley, Maryland · www.pharm-int.com
Paragonix Technologies, Inc. 2024-08-22 - Trade Sale
Waltham, Massachusetts · www.paragonixtechnologies.com
Curida AS 2024-04-16 - Growth Capital
Oslo, Norway · www.curida.no
Paragonix Technologies, Inc. 2023-03-07 - Growth Capital
Waltham, Massachusetts · www.paragonixtechnologies.com
Laxai Life Sciences Pvt Ltd. 2022-10-24 - Growth Capital
Hyderabad, India · www.laxai.com
Juno Pharmaceuticals Corp. 2022-02-24 - Growth Capital
Mississauga, Ontario · www.junopharm.ca
Ascendia Pharmaceuticals 2021-04-08 - Growth Capital
North Brunswick, New Jersey · www.ascendiapharma.com
Algorithme Pharma, Inc. 2021-02-22 - Secondary Buyout
Laval, Quebec · www.altasciences.com
RK Pharma, Inc. 2019-08-05 - Growth Capital
Pearl River, New York · www.rkpharmainc.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 12 (92%) - 13 (81%) -
Medical Products 1 (8%) - 3 (19%) -
Total 13 - 16 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 5 (38%) - 8 (50%) -
  New Jersey 3 (23%) - 3 (19%) -
  New York 1 (8%) - 1 (6%) -
  Florida 1 (8%) - 1 (6%) -
  Massachusetts - - 1 (6%) -
  Maryland - - 1 (6%) -
  California - - 1 (6%) -
Canada 2 (15%) - 2 (13%) -
  Ontario 1 (8%) - 1 (6%) -
  Quebec 1 (8%) - 1 (6%) -
Germany 1 (8%) - 1 (6%) -
India 1 (8%) - 1 (6%) -
Denmark 1 (8%) - 1 (6%) -
Israel 1 (8%) - 1 (6%) -
Norway 1 (8%) - 1 (6%) -
Sweden 1 (8%) - 1 (6%) -
Total 13 - 16 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Growth Capital 9 (69%) - 11 (69%) -
Venture 3 (23%) - 4 (25%) -
Secondary Buyout 1 (8%) - 1 (6%) -
Total 13 - 16 -

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 2 (100%) -
Total 2 -

Top M&A Advisors

Legal Deals
Sheppard Mullin Richter & Hampton
 6
Advokatfirmaet Selmer DA
 1
Advokatfirman Delphi
 1

M&A Connections

Deals
Acquired from
Investor(s)
6%
1 (6%)
Exited to
Strategic(s)
100%
2 (100%)

Investor Summary

Investor Type

Growth Capital Firm

Size

Middle-Market

PE Assets

600M USD

Established

1998

Specialist/Generalist

Specialist

Leadership

James Gale

Founding Partner & Managing Director

Ashley Friedman

Managing Director

Nikhil Puri

Managing Director

Theron Odlaug

Operating Partner

FAQ

When was Signet Healthcare Partners founded?

Signet Healthcare Partners was founded in 1998.

What type of investor is Signet Healthcare Partners?

Signet Healthcare Partners is a growth capital firm.

Where is Signet Healthcare Partners headquartered?

Signet Healthcare Partners is headquartered in New York, United States.

How much capital does Signet Healthcare Partners have under management?

Signet Healthcare Partners has 600M USD under management.

 Subscribe to unlock this and 214,646
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal